SkinHealth Systems Inc. (SKIN) Stock Competitors & Peer Comparison
See (SKIN) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SKIN | $0.75 | -0.91% | 97.8M | -4.44 | -$0.17 | N/A |
| PG | $149.13 | +0.70% | 347.3B | 21.49 | $6.94 | +2.85% |
| UL | $61.83 | +1.71% | 133.2B | 20.34 | $3.04 | +3.68% |
| CL | $91.63 | +1.25% | 73.3B | 24.43 | $3.75 | +2.29% |
| KVUE | $19.13 | +0.63% | 36.7B | 16.49 | $1.16 | +4.34% |
| KMB | $108.88 | +0.77% | 36.1B | 14.38 | $7.57 | +4.66% |
| EL | $82.63 | +0.32% | 29.9B | 37.39 | $2.21 | +1.69% |
| CHD | $97.13 | +1.44% | 23B | 27.28 | $3.56 | +1.25% |
| CLX | $95.76 | +0.07% | 11.6B | 14.19 | $6.75 | +5.18% |
| REYN | $25.98 | +0.58% | 5.5B | 15.46 | $1.68 | +3.54% |
Stock Comparison
SKIN vs PG Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, PG has a market cap of 347.3B. Regarding current trading prices, SKIN is priced at $0.75, while PG trades at $149.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas PG's P/E ratio is 21.49. In terms of profitability, SKIN's ROE is -0.09%, compared to PG's ROE of +0.31%. Regarding short-term risk, SKIN is more volatile compared to PG. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check PG's competition here
SKIN vs UL Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, UL has a market cap of 133.2B. Regarding current trading prices, SKIN is priced at $0.75, while UL trades at $61.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas UL's P/E ratio is 20.34. In terms of profitability, SKIN's ROE is -0.09%, compared to UL's ROE of +0.36%. Regarding short-term risk, SKIN is more volatile compared to UL. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check UL's competition here
SKIN vs CL Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, CL has a market cap of 73.3B. Regarding current trading prices, SKIN is priced at $0.75, while CL trades at $91.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas CL's P/E ratio is 24.43. In terms of profitability, SKIN's ROE is -0.09%, compared to CL's ROE of +4.75%. Regarding short-term risk, SKIN is more volatile compared to CL. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check CL's competition here
SKIN vs KVUE Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, KVUE has a market cap of 36.7B. Regarding current trading prices, SKIN is priced at $0.75, while KVUE trades at $19.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas KVUE's P/E ratio is 16.49. In terms of profitability, SKIN's ROE is -0.09%, compared to KVUE's ROE of +0.15%. Regarding short-term risk, SKIN is more volatile compared to KVUE. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check KVUE's competition here
SKIN vs KMB Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, KMB has a market cap of 36.1B. Regarding current trading prices, SKIN is priced at $0.75, while KMB trades at $108.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas KMB's P/E ratio is 14.38. In terms of profitability, SKIN's ROE is -0.09%, compared to KMB's ROE of +1.44%. Regarding short-term risk, SKIN is more volatile compared to KMB. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check KMB's competition here
SKIN vs EL Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, EL has a market cap of 29.9B. Regarding current trading prices, SKIN is priced at $0.75, while EL trades at $82.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas EL's P/E ratio is 37.39. In terms of profitability, SKIN's ROE is -0.09%, compared to EL's ROE of -0.06%. Regarding short-term risk, SKIN is more volatile compared to EL. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check EL's competition here
SKIN vs CHD Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, CHD has a market cap of 23B. Regarding current trading prices, SKIN is priced at $0.75, while CHD trades at $97.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas CHD's P/E ratio is 27.28. In terms of profitability, SKIN's ROE is -0.09%, compared to CHD's ROE of +0.17%. Regarding short-term risk, SKIN is more volatile compared to CHD. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check CHD's competition here
SKIN vs CLX Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, CLX has a market cap of 11.6B. Regarding current trading prices, SKIN is priced at $0.75, while CLX trades at $95.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas CLX's P/E ratio is 14.19. In terms of profitability, SKIN's ROE is -0.09%, compared to CLX's ROE of +28.26%. Regarding short-term risk, SKIN is more volatile compared to CLX. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check CLX's competition here
SKIN vs REYN Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, REYN has a market cap of 5.5B. Regarding current trading prices, SKIN is priced at $0.75, while REYN trades at $25.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas REYN's P/E ratio is 15.46. In terms of profitability, SKIN's ROE is -0.09%, compared to REYN's ROE of +0.15%. Regarding short-term risk, SKIN is more volatile compared to REYN. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check REYN's competition here
SKIN vs ELF Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, ELF has a market cap of 4.7B. Regarding current trading prices, SKIN is priced at $0.75, while ELF trades at $79.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas ELF's P/E ratio is 25.23. In terms of profitability, SKIN's ROE is -0.09%, compared to ELF's ROE of +0.02%. Regarding short-term risk, SKIN is more volatile compared to ELF. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check ELF's competition here
SKIN vs NTCO Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, SKIN is priced at $0.75, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas NTCO's P/E ratio is -11.37. In terms of profitability, SKIN's ROE is -0.09%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, SKIN is more volatile compared to NTCO. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check NTCO's competition here
SKIN vs IPAR Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, IPAR has a market cap of 3.9B. Regarding current trading prices, SKIN is priced at $0.75, while IPAR trades at $122.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas IPAR's P/E ratio is 23.19. In terms of profitability, SKIN's ROE is -0.09%, compared to IPAR's ROE of +0.19%. Regarding short-term risk, SKIN is more volatile compared to IPAR. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check IPAR's competition here
SKIN vs COTY Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, COTY has a market cap of 2.4B. Regarding current trading prices, SKIN is priced at $0.75, while COTY trades at $2.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas COTY's P/E ratio is 15.19. In terms of profitability, SKIN's ROE is -0.09%, compared to COTY's ROE of -0.15%. Regarding short-term risk, SKIN is more volatile compared to COTY. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check COTY's competition here
SKIN vs NWL Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, NWL has a market cap of 2.2B. Regarding current trading prices, SKIN is priced at $0.75, while NWL trades at $5.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas NWL's P/E ratio is 9.65. In terms of profitability, SKIN's ROE is -0.09%, compared to NWL's ROE of -0.11%. Regarding short-term risk, SKIN is more volatile compared to NWL. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check NWL's competition here
SKIN vs SPB Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, SPB has a market cap of 2.1B. Regarding current trading prices, SKIN is priced at $0.75, while SPB trades at $89.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas SPB's P/E ratio is 13.68. In terms of profitability, SKIN's ROE is -0.09%, compared to SPB's ROE of +0.07%. Regarding short-term risk, SKIN is more volatile compared to SPB. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check SPB's competition here
SKIN vs EPC Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, EPC has a market cap of 1.3B. Regarding current trading prices, SKIN is priced at $0.75, while EPC trades at $27.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas EPC's P/E ratio is 13.54. In terms of profitability, SKIN's ROE is -0.09%, compared to EPC's ROE of -0.05%. Regarding short-term risk, SKIN is more volatile compared to EPC. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check EPC's competition here
SKIN vs HELE Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, HELE has a market cap of 656.6M. Regarding current trading prices, SKIN is priced at $0.75, while HELE trades at $28.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas HELE's P/E ratio is 8.54. In terms of profitability, SKIN's ROE is -0.09%, compared to HELE's ROE of -0.48%. Regarding short-term risk, SKIN is more volatile compared to HELE. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check HELE's competition here
SKIN vs USNA Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, USNA has a market cap of 410.2M. Regarding current trading prices, SKIN is priced at $0.75, while USNA trades at $22.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas USNA's P/E ratio is 12.34. In terms of profitability, SKIN's ROE is -0.09%, compared to USNA's ROE of +0.02%. Regarding short-term risk, SKIN is more volatile compared to USNA. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check USNA's competition here
SKIN vs YSG Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, YSG has a market cap of 325.8M. Regarding current trading prices, SKIN is priced at $0.75, while YSG trades at $3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas YSG's P/E ratio is -27.19. In terms of profitability, SKIN's ROE is -0.09%, compared to YSG's ROE of -0.05%. Regarding short-term risk, SKIN is less volatile compared to YSG. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check YSG's competition here
SKIN vs EWCZ Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, EWCZ has a market cap of 319.1M. Regarding current trading prices, SKIN is priced at $0.75, while EWCZ trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, SKIN's ROE is -0.09%, compared to EWCZ's ROE of +0.10%. Regarding short-term risk, SKIN is more volatile compared to EWCZ. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check EWCZ's competition here
SKIN vs NUS Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, NUS has a market cap of 254.9M. Regarding current trading prices, SKIN is priced at $0.75, while NUS trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas NUS's P/E ratio is 4.38. In terms of profitability, SKIN's ROE is -0.09%, compared to NUS's ROE of +0.07%. Regarding short-term risk, SKIN is more volatile compared to NUS. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check NUS's competition here
SKIN vs WALD Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, WALD has a market cap of 209.3M. Regarding current trading prices, SKIN is priced at $0.75, while WALD trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas WALD's P/E ratio is -2.95. In terms of profitability, SKIN's ROE is -0.09%, compared to WALD's ROE of -0.48%. Regarding short-term risk, SKIN is more volatile compared to WALD. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check WALD's competition here
SKIN vs PTNM Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, SKIN is priced at $0.75, while PTNM trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas PTNM's P/E ratio is 346.33. In terms of profitability, SKIN's ROE is -0.09%, compared to PTNM's ROE of -0.99%. Regarding short-term risk, SKIN is more volatile compared to PTNM. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check PTNM's competition here
SKIN vs ACU Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, ACU has a market cap of 174.9M. Regarding current trading prices, SKIN is priced at $0.75, while ACU trades at $45.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas ACU's P/E ratio is 19.78. In terms of profitability, SKIN's ROE is -0.09%, compared to ACU's ROE of +0.08%. Regarding short-term risk, SKIN is more volatile compared to ACU. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check ACU's competition here
SKIN vs UPXI Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, UPXI has a market cap of 63.3M. Regarding current trading prices, SKIN is priced at $0.75, while UPXI trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas UPXI's P/E ratio is -0.19. In terms of profitability, SKIN's ROE is -0.09%, compared to UPXI's ROE of -3.07%. Regarding short-term risk, SKIN is more volatile compared to UPXI. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check UPXI's competition here
SKIN vs SLSN Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, SLSN has a market cap of 60.2M. Regarding current trading prices, SKIN is priced at $0.75, while SLSN trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas SLSN's P/E ratio is 69.31. In terms of profitability, SKIN's ROE is -0.09%, compared to SLSN's ROE of +0.05%. Regarding short-term risk, SKIN is less volatile compared to SLSN. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check SLSN's competition here
SKIN vs GROV Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, GROV has a market cap of 45.8M. Regarding current trading prices, SKIN is priced at $0.75, while GROV trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas GROV's P/E ratio is -4.19. In terms of profitability, SKIN's ROE is -0.09%, compared to GROV's ROE of -1.06%. Regarding short-term risk, SKIN is more volatile compared to GROV. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check GROV's competition here
SKIN vs AXIL Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, AXIL has a market cap of 37M. Regarding current trading prices, SKIN is priced at $0.75, while AXIL trades at $5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas AXIL's P/E ratio is 45.17. In terms of profitability, SKIN's ROE is -0.09%, compared to AXIL's ROE of +0.09%. Regarding short-term risk, SKIN is more volatile compared to AXIL. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check AXIL's competition here
SKIN vs UG Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, UG has a market cap of 36.5M. Regarding current trading prices, SKIN is priced at $0.75, while UG trades at $7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas UG's P/E ratio is 15.29. In terms of profitability, SKIN's ROE is -0.09%, compared to UG's ROE of +0.21%. Regarding short-term risk, SKIN is more volatile compared to UG. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check UG's competition here
SKIN vs DSY Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, DSY has a market cap of 14.6M. Regarding current trading prices, SKIN is priced at $0.75, while DSY trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas DSY's P/E ratio is -0.34. In terms of profitability, SKIN's ROE is -0.09%, compared to DSY's ROE of +14.77%. Regarding short-term risk, SKIN is less volatile compared to DSY. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check DSY's competition here
SKIN vs PHH Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, PHH has a market cap of 10M. Regarding current trading prices, SKIN is priced at $0.75, while PHH trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas PHH's P/E ratio is -0.53. In terms of profitability, SKIN's ROE is -0.09%, compared to PHH's ROE of +0.38%. Regarding short-term risk, SKIN is less volatile compared to PHH. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check PHH's competition here
SKIN vs BRSH Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, SKIN is priced at $0.75, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas BRSH's P/E ratio is -0.01. In terms of profitability, SKIN's ROE is -0.09%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, SKIN is less volatile compared to BRSH. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check BRSH's competition here
SKIN vs MTEX Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, MTEX has a market cap of 8.5M. Regarding current trading prices, SKIN is priced at $0.75, while MTEX trades at $4.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas MTEX's P/E ratio is -0.66. In terms of profitability, SKIN's ROE is -0.09%, compared to MTEX's ROE of -23.83%. Regarding short-term risk, SKIN is more volatile compared to MTEX. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check MTEX's competition here
SKIN vs TANH Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, TANH has a market cap of 2.9M. Regarding current trading prices, SKIN is priced at $0.75, while TANH trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas TANH's P/E ratio is 0.05. In terms of profitability, SKIN's ROE is -0.09%, compared to TANH's ROE of -0.25%. Regarding short-term risk, SKIN is less volatile compared to TANH. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check TANH's competition here
SKIN vs BYAH Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, BYAH has a market cap of 291.3K. Regarding current trading prices, SKIN is priced at $0.75, while BYAH trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas BYAH's P/E ratio is N/A. In terms of profitability, SKIN's ROE is -0.09%, compared to BYAH's ROE of -6.53%. Regarding short-term risk, SKIN is less volatile compared to BYAH. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check BYAH's competition here
SKIN vs BRSHW Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, SKIN is priced at $0.75, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas BRSHW's P/E ratio is N/A. In terms of profitability, SKIN's ROE is -0.09%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, SKIN is less volatile compared to BRSHW. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check BRSHW's competition here
SKIN vs GROV-WT Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, SKIN is priced at $0.75, while GROV-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, SKIN's ROE is -0.09%, compared to GROV-WT's ROE of -1.06%. Regarding short-term risk, SKIN is more volatile compared to GROV-WT. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check GROV-WT's competition here
SKIN vs RDEN Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, RDEN has a market cap of 0. Regarding current trading prices, SKIN is priced at $0.75, while RDEN trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas RDEN's P/E ratio is -5.68. In terms of profitability, SKIN's ROE is -0.09%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, SKIN is more volatile compared to RDEN. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check RDEN's competition here
SKIN vs REV Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, REV has a market cap of 0. Regarding current trading prices, SKIN is priced at $0.75, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas REV's P/E ratio is -1.19. In terms of profitability, SKIN's ROE is -0.09%, compared to REV's ROE of +0.89%. Regarding short-term risk, SKIN is more volatile compared to REV. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check REV's competition here
SKIN vs SUMR Comparison July 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 97.8M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, SKIN is priced at $0.75, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.44, whereas SUMR's P/E ratio is -3.66. In terms of profitability, SKIN's ROE is -0.09%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, SKIN is more volatile compared to SUMR. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check SUMR's competition here